BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

AtheroNova Inc. 

PO Box 4198

Newport Beach  California    U.S.A.
Phone: 949-903-0468 Fax:


SEARCH JOBS




Industry
Biotechnology






 Company News
AtheroNova Inc. (AHRO.OB) Prices Public Offering Of Common Stock And Warrants 10/29/2014 7:48:27 AM
AtheroNova Inc. (AHRO.OB) Announces Milestone With Initiation Of Phase 1b Clinical Trial Of AHRO-001 7/30/2014 8:09:21 AM
AtheroNova Inc. (AHRO.OB) Announces Pre-IND Filing Under Section 505(b)(2) 7/15/2014 6:34:14 AM
AtheroNova Inc. (AHRO.OB) Announces Russian Ministry Of Healthcare Approval For Initiation Of Phase 1b Trial Investigating AHRO-001 5/28/2014 9:06:41 AM
AtheroNova Inc. (AHRO.OB) Announces Q1 2014 Financial Results/Highlights 5/19/2014 9:39:17 AM
AtheroNova Inc. (AHRO.OB) Receives Notice Of Issuance Of Its 2nd US Patent 8,697,633 5/8/2014 10:08:56 AM
AtheroNova Inc. (AHRO.OB) 1-For-10 Reverse Stock Split Effective 4/22/2014 9:14:35 AM
AtheroNova Inc. (AHRO.OB) Appoints Dr. Randolph M. Johnson As Chief Operating Officer 4/8/2014 7:28:27 AM
AtheroNova Inc. (AHRO.OB) Announces 2013 Financial Results 3/6/2014 9:19:48 AM
AtheroNova Inc. (AHRO.OB) Announces Preliminary Positive Phase 1 Clinical Data From Lead Drug AHRO-001, A Potential Treatment For Atherosclerosis 2/27/2014 9:17:04 AM
1234567